Skip to content

Bicara Therapeutics

US · BCAX #3193 by market cap Listed 2024
16.42 -0.14 -0.85%
Live - 5344 symbols - heartbeat 24s ago · 2026-10-08 09:20
Pre-market 18.00 +9.62%
After-hours 16.42 0.00%
Market cap
1.09B
P/B
2.32
EPS
-2.52
Reader sentiment Are you bullish or bearish on BCAX?

Anonymous reader poll. Unscientific, not investment advice.

Analyst consensus 6 analysts

Buy
Avg price target 36.67 +123.3%
Price target rangecurrent 16.42
Low30.00
Avg36.67
High45.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-07 BMO Capital -- BUY 35.00
2026-09-08 JonesTrading -- BUY 30.00
2026-08-18 BMO Capital -- BUY 35.00
2026-08-13 Stifel -- BUY 45.00
2026-08-12 BTIG -- BUY 39.00
2026-08-12 Morgan Stanley -- BUY 37.00
2026-08-11 JonesTrading -- BUY 30.00
2026-08-11 BofA Securities -- BUY 34.00
2026-07-27 BTIG -- BUY 28.00
2026-06-02 BofA Securities -- BUY --
2026-06-01 H.C. Wainwright -- BUY 42.00
2026-05-26 Guggenheim -- BUY 42.00
2026-05-22 JonesTrading -- BUY 30.00
2026-05-22 BofA Securities -- BUY --
2026-05-12 Morgan Stanley -- BUY 37.00
2026-05-12 Stifel -- BUY 46.00
2026-05-11 TD Cowen -- BUY --
2026-05-11 JonesTrading -- BUY 30.00
2026-05-11 BTIG -- BUY 28.00
2026-05-11 BofA Securities -- BUY 35.00
2026-05-11 Morgan Stanley -- BUY 37.00
2026-05-10 Guggenheim -- BUY 42.00
2026-03-31 Morgan Stanley -- BUY 36.00
2026-03-31 H.C. Wainwright -- BUY 42.00
2026-03-30 TD Cowen -- BUY --

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q2 2026-08-11 -- ±11.74% -14.32% (beat)
2026/Q1 2026-05-11 -- -- +1.51%
2025/Q4 2026-03-30 -- -- +3.65%

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-08 09:20:27 · For reference only, not investment advice and not tailored to your situation.